KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical-stage pharmaceutical company specializing in the discovery, development, and commercialization of oral, small molecule protease inhibitors, has announced today that the UK Medicines and…
argenx SE (Euronext & Nasdaq: ARGX), a global immunology company dedicated to enhancing the well-being of individuals with severe autoimmune conditions, has announced today that the U.S. Food and Drug…
Diakonos Oncology Corp. (“Diakonos”), a company in the clinical stage of immuno-oncology, has announced today the appointment of Dr. Paul Lammers, M.D., M.Sc., a distinguished executive with over 35 years…
Celltrion Healthcare Canada Limited has announced today that Health Canada has granted approval for Remsima™ SC as maintenance therapy for adults with moderately to severely active ulcerative colitis (UC) and…
MRM Health, a clinical-stage biopharmaceutical firm, has obtained regulatory and ethics committee approval to commence an observational, cross-sectional clinical trial examining the role of the small intestinal microbiome in Parkinson’s…
AbbVie has revealed that 17 AbbVie-sponsored abstracts, featuring fresh insights from its inflammatory bowel disease (IBD) portfolio, have been accepted for showcase at the 19th Congress of European Crohn’s and…
Leading global pharmaceutical company Lupin Limited (Lupin) has announced its receipt of approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for…
EffRx Pharmaceuticals SA, a pharmaceutical company specializing in musculoskeletal and rare diseases medications, has disclosed the signing of an exclusive licensing and distribution arrangement for Binosto® in Vietnam and the…
Leading global pharmaceutical company Lupin Limited (Lupin) has announced the introduction of Ganirelix Acetate Injection, 250 mcg mL, Single-Dose Prefilled Syringe, following approval from the United States Food and Drug…
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) revealed today that it has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for its experimental drug olezarsen. This designation is…
The COVID-19 pandemic has brought to light the vulnerabilities inherent in global supply chains, especially affecting the access of low- and middle-income countries (LMICs) to crucial medical supplies. The disproportionate…
Approximately 80% of the global population faces the threat of contracting one or more vector-borne diseases, with mosquitoes, flies, bugs, and other vectors transmitting viruses, parasites, and bacteria to millions…